A mind boggling balance sheet comparison:
NST: Net assets - $244m, NTA/share - $0.33
SLR: Net assets- $276m, NTA/share - $0.55
Assuming the market is right, then arguably one of these balance sheets needs to be impaired or the other one needs to be repaired. I also confess my hatred of accountants.
- Forums
- ASX - By Stock
- NST
- Ann: Preliminary Final Report 30 June 2014
Ann: Preliminary Final Report 30 June 2014, page-15
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NST (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.97 |
Change
0.110(0.79%) |
Mkt cap ! $15.93B |
Open | High | Low | Value | Volume |
$13.85 | $13.99 | $13.78 | $24.59M | 1.770M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 5579 | $13.97 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.98 | 20279 | 39 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 4378 | 13.970 |
12 | 11382 | 13.960 |
23 | 11522 | 13.950 |
10 | 5683 | 13.940 |
9 | 4482 | 13.930 |
Price($) | Vol. | No. |
---|---|---|
13.980 | 5363 | 16 |
13.990 | 26935 | 30 |
14.000 | 17601 | 19 |
14.010 | 9399 | 7 |
14.020 | 19373 | 10 |
Last trade - 15.38pm 15/07/2024 (20 minute delay) ? |
Featured News
NST (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online